Publications by authors named "Roger A Barker"

98Publications

Correction to: The Treatment of Sleep Dysfunction in Neurodegenerative Disorders.

Neurotherapeutics 2020 Dec 18. Epub 2020 Dec 18.

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, NR4 7TJ, UK.

View Article and Find Full Text PDF
December 2020

The Treatment of Sleep Dysfunction in Neurodegenerative Disorders.

Neurotherapeutics 2020 Nov 11. Epub 2020 Nov 11.

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, NR4 7TJ, UK.

View Article and Find Full Text PDF
November 2020

Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?

Neurotherapeutics 2020 Oct 30. Epub 2020 Oct 30.

Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Hills Road, CB2 0QQ, Cambridge, UK.

View Article and Find Full Text PDF
October 2020

Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease.

Mov Disord 2020 Oct 30. Epub 2020 Oct 30.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

View Article and Find Full Text PDF
October 2020

Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease.

Mov Disord 2020 Oct 1. Epub 2020 Oct 1.

Biomedical Ethics Unit, Studies of Translation, Ethics and Medicine (STREAM) Research Group, McGill University, Montreal, Quebec, Canada.

View Article and Find Full Text PDF
October 2020

Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson's disease.

Neuroimage Clin 2020 2;28:102409. Epub 2020 Sep 2.

Centre for Neurodegeneration and Neuroinflammation, Division of Brain Sciences, Imperial College London, London W12 0NN, United Kingdom.

View Article and Find Full Text PDF
September 2020

3D-Printed Soft Lithography for Complex Compartmentalized Microfluidic Neural Devices.

Adv Sci (Weinh) 2020 Aug 15;7(16):2001150. Epub 2020 Jun 15.

Department of Biotechnology and Biomedicine (DTU Bioengineering) Technical University of Denmark Produktionstorvet, Building 423 Lyngby 2800 Kgs. Denmark.

View Article and Find Full Text PDF
August 2020

Recent developments in the treatment of Parkinson's Disease.

F1000Res 2020 31;9. Epub 2020 Jul 31.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK.

View Article and Find Full Text PDF
October 2020

Huntingtin-lowering strategies for Huntington's disease.

Expert Opin Investig Drugs 2020 Oct 14;29(10):1125-1132. Epub 2020 Aug 14.

Department of Medical Genetics, Cambridge Institute for Medical Research , Cambridge, UK.

View Article and Find Full Text PDF
October 2020

Animal Models of Parkinson's Disease: Are They Useful or Not?

J Parkinsons Dis 2020 ;10(4):1335-1342

Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden.

View Article and Find Full Text PDF
January 2020

The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease Patients.

J Huntingtons Dis 2020 ;9(3):275-282

Department of Clinical Neuroscience, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF
January 2020

Corrigendum to "DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits". Neurobiology of Disease 134 (2020) 104629.

Neurobiol Dis 2020 Aug 20;142:104971. Epub 2020 Jun 20.

TTK-NAP B - Drug Discovery Research Group - Neurodegenerative Diseases, Institute of Organic Chemistry, Research Center for Natural Sciences, Budapest, Hungary; Cantabio Pharmaceuticals, Sunnyvale, California, USA; Molecular Imaging Chemistry Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK. Electronic address:

View Article and Find Full Text PDF
August 2020

Cerebrospinal Fluid Cytokines and Neurodegeneration-Associated Proteins in Parkinson's Disease.

Mov Disord 2020 06 4;35(6):1062-1066. Epub 2020 Mar 4.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

View Article and Find Full Text PDF
June 2020

Forecasts for the Attainment of Major Research Milestones in Parkinson's Disease.

J Parkinsons Dis 2020 ;10(3):1047-1055

Biomedical Ethics Unit, STREAM Research Group, McGill University, Montreal, QC, Canada.

View Article and Find Full Text PDF
January 2020

Impact of variants on long-term clinical progression and mortality in incident Parkinson's disease.

J Neurol Neurosurg Psychiatry 2020 07 17;91(7):695-702. Epub 2020 Apr 17.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, Cambridgeshire, UK.

View Article and Find Full Text PDF
July 2020

A common polymorphism in is associated with accelerated motor decline in -Parkinson's disease.

J Neurol Neurosurg Psychiatry 2020 06 2;91(6):673-674. Epub 2020 Apr 2.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF
June 2020

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington's disease (Enroll-HD).

J Neurol Neurosurg Psychiatry 2020 06 30;91(6):622-630. Epub 2020 Mar 30.

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, and MRC-WT Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

View Article and Find Full Text PDF
June 2020

Serum Raman spectroscopy as a diagnostic tool in patients with Huntington's disease.

Chem Sci 2020 Jan 14;11(2):525-533. Epub 2019 Nov 14.

John van Geest Centre for Brain Repair , the WT-MRC Cambridge Stem Cell Institute , University of Cambridge , Forvie Site, Robinson Way , Cambridge , CB2 0PY , UK . Email:

View Article and Find Full Text PDF
January 2020

Informed Consent for Stem Cell-Based Interventions-Reply.

JAMA 2020 03;323(9):894

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland.

View Article and Find Full Text PDF
March 2020

Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?

Neurology 2020 03 26;94(11):481-494. Epub 2020 Feb 26.

From the Department of Neurology (A.J.E.), James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, OH; Edmond J. Safra Program in Parkinson's Disease (L.V.K.), Krembil Research Institute, Toronto Western Hospital, Ontario, Canada; Department of Neurology and Neurosurgery (Z.G.-O.), Montreal Neurological Institute, and Department of Human Genetics (Z.G.-O.), McGill University, Montreal, Quebec, Canada; Department of Clinical Neurosciences (C.H.W.-G.), John van Geest Centre for Brain Repair, University of Cambridge, UK; Division of Medical Oncology and Hematology (P.L.B.), Princess Margaret Cancer Centre, University Health Network, and Department of Medicine (P.L.B.), University of Toronto, Ontario, Canada; Departments of Medicine (S.M.R.), Pediatrics (S.M.R.), Cell Developmental and Integrative Biology (S.M.R.), and Neurology (D.G.S.), University of Alabama at Birmingham; Department of Clinical and Experimental Medicine (F.M.), University of Messina, Italy; Institute of Molecular and Clinical Sciences (F.M.), St George's University of London, UK; Edmond J. Safra Program in Parkinson's Disease (A.F., A.P.S., A.E.L.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University of Toronto; Krembil Research Institute (A.F., A.P.S., A.E.L.); Tomorrow Edition (B.S.), Toronto, Ontario, Canada; Consultorio y Laboratorio de Neurogenética (M.A.K.), Centro Universitario de Neurología "José María Ramos Mejía" y División Neurología, Hospital JM Ramos Mejía, Facultad de Medicina, UBA; Programa de Medicina de Precision y Genomica Clinica (M.A.K.), Instituto de Investigaciones en Medicina Traslacional, Facultad de Ciencias Biomédicas, Universidad Austral-CONICET, Buenos Aires, Argentina; Clinical Genomics Program (M.J.F.), Norman Fixel Institute for Neurological Diseases, McKnight Brain Institute, University of Florida Clinical and Translational Science Institute, Gainesville; Clinical Trials Statistical & Data Management Center (C.S.C.), University of Iowa College of Public Health, Iowa City; Department of Neurology (M.A.S.), Massachusetts General Hospital, Boston; Michael J. Fox Foundation for Parkinson's Research (T.S.), New York City, NY; Department of Neurology (R.B.P.), Montreal General Hospital, Quebec; Research Imaging Centre (A.P.S.), Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada; Laboratory of Neurogenetics (A.B.S.), National Institute on Aging, NIH, Bethesda, MD; Department of Clinical Neurosciences (R.A.B.), John van Geest Centre for Brain Repair, WT-MRC Cambridge Stem Cell Institute, University of Cambridge, UK; Clinical Trials Coordination Center (K.K.), University of Rochester Medical Center, NY; Department of Neurology and Neuroscience (C.W.O.), Mount Sinai School of Medicine, New York, NY; Clintrex LLC (C.W.O.), Sarasota, FL; Division of Neurosurgery (A.L.), Krembil Neuroscience Institute, Toronto Western Hospital, Ontario, Canada; Department of Neurological Sciences (J.H.K.), Rush University Medical Center, Chicago, IL; Coeruleus Clinical Sciences (J.M.C.), Woodbridge, CT; and Center for Neurodegenerative Science (P.B.), Van Andel Institute, Grand Rapids, MI.

View Article and Find Full Text PDF
March 2020

Parkinson's disease and spirituality.

NeuroRehabilitation 2020 ;46(1):31-39

Faraday Institute for Science and Religion, Cambridge, UK.

View Article and Find Full Text PDF
July 2020

Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease.

Brain Behav Immun 2020 07 30;87:473-488. Epub 2020 Jan 30.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK.

View Article and Find Full Text PDF
July 2020

Motor complications in Parkinson's disease: 13-year follow-up of the CamPaIGN cohort.

Mov Disord 2020 01 11;35(1):185-190. Epub 2019 Nov 11.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF
January 2020

Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease.

Mol Psychiatry 2019 Nov 22. Epub 2019 Nov 22.

John van Geest Centre for Brain Repair, Department of Clinical Neuroscience, University of Cambridge, Cambridge, CB2 0PY, UK.

View Article and Find Full Text PDF
November 2019

DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits.

Neurobiol Dis 2020 02 11;134:104629. Epub 2019 Nov 11.

TTK-NAP B - Drug Discovery Research Group - Neurodegenerative Diseases, Institute of Organic Chemistry, Research Center for Natural Sciences, Budapest, Hungary; Cantabio Pharmaceuticals, Palo Alto, CA, USA. Electronic address:

View Article and Find Full Text PDF
February 2020

Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons.

FEBS Lett 2019 12 10;593(23):3370-3380. Epub 2019 Oct 10.

Department of Experimental Medical Science, Wallenberg Neuroscience Center, Division of Neurobiology, Lund Stem Cell Center, Lund University, Sweden.

View Article and Find Full Text PDF
December 2019

Huntington's disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory.

Cortex 2019 10 13;119:417-427. Epub 2019 Aug 13.

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF
October 2019

Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD.

Mov Disord 2019 11 23;34(11):1690-1698. Epub 2019 Aug 23.

Faculty of Medical Science, Newcastle University, Newcastle Upon Tyne, UK.

View Article and Find Full Text PDF
November 2019

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

Neurol Genet 2019 Aug 9;5(4):e348. Epub 2019 Jul 9.

Laboratory of Neurogenetics (H.I., C.B., H.L.L., F.F., D.G.H., A.B.S., M.A.N.), National Institute on Aging, National Institutes of Health, Bethesda; Data Tecnica International (H.I., M.A.N.), Glen Echo, MD; Precision Neurology Program (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Neurogenomics Laboratory (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Ann Romney Center for Neurologic Diseases (G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; The Norwegian Centre for Movement Disorders (J.M.-G., G.A.), Stavanger University Hospital; Department of Chemistry (J.M.-G., G.A.), Bioscience and Environmental Engineering, University of Stavanger, Norway; Assistance-Publique Hôpitaux de Paris (J.-C.C.), ICM, INSERM UMRS 1127, CNRS 7225, ICM, Department of Neurology and CIC Neurosciences, Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology (L.P., M.T.), Oslo University Hospital, Norway; Department of Neurology (M.N., B.R.B., B.P.W.), Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands; Michael J Fox Foundation (S.J.H.), New York; Translational Genome Sciences (K.-D.H.N, K.E.), Biogen, Cambridge, MA; Department of Neurology University of Pennsylvania (J.R.), Philadelphia, PA; Department of Biostatistics and Computational Biology (S.E.), University of Rochester, NY; Department of Computer Science (F.F.), University of Illinois Urbana-Champaign; Department of Neurology (P.A.), Center for Health + Technology, University of Rochester, NY; Department of Clinical Neurosciences (K.M.S., R.W.), University of Cambridge, John van Geest Centre for Brain Repair, UK; Department of Pathology and Laboratory Medicine (V.M.V.D.), Center for Neurodegenerative Disease Research, Parelman School of Medicine at the University of Pennsylvania, Philadelphia; Genetics and Pharmacogenomics (A.G.D.-W.), Merck Research Laboratory, Boston, MA; Statistical Genetics (A.G.D.-W.), Biogen, Cambridge, MA; Institut du cerveau et de la moelle épinière ICM (A.B., F.D.); Sorbonne Université SU (A.B.); INSERM UMR (A.B.), Paris, France; Department of Neurology (G.A.), Stavanger University Hospital, Norway; Preventive Neurology Unit (A.J.N.), Wolfson Institute of Preventive Medicine, Queen Mary University of London; Department of Molecular Neuroscience (A.J.N.), UCL Institute of Neurology, London, UK; Department of Neurology (O.-B.T.), Haukeland University Hospital; University of Bergen (O.-B.T.), Bergen, Norway; Department of Neurology (J.R.E.), Nottingham University NHS Trust, UK; Centre for Clinical Brain Sciences (D.P.B.), University of Edinburgh; Anne Rowling Regenerative Neurology Clinic (D.P.B.), University of Edinburgh; Usher Institute of Population Health Sciences and Informatics (D.P.B.), University of Edinburgh, Scotland; Department of Medical and Molecular Genetics (C.E.W.), Indiana University, Indianapolis; Department of Neurology (D.K.S.), Beth Israel Deaconess Medical Center; Harvard Medical School (D.K.S.), Boston; Voyager Therapeutics (B.R.), Cambridge, MA; Department of Neurology (B.R.), University of Rochester School of Medicine, NY; Institute of Clinical Medicine (M.T.), University of Oslo, Norway; German Center for Neurodegenerative Diseases-Tubingen (P.H.); HIH Tuebingen (P.H.), Germany; Department of Psychiatry (D.W.), University of Pennsylvania School of Medicine; Department of Veterans Affairs (D.W.), Philadelphia, PA; and Department of Clinical Neurosciences (R.A.B., C.H.W.-G.), University of Cambridge, UK; Department of Neurology (J.J.V.H.), Leiden University Medical Center, The Netherlands.

View Article and Find Full Text PDF
August 2019

A Professional Standard for Informed Consent for Stem Cell Therapies.

JAMA 2019 Aug 12. Epub 2019 Aug 12.

University of Wisconsin Law School, Madison.

View Article and Find Full Text PDF
August 2019

Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease.

Authors:
Roger A Barker

Nat Med 2019 07 1;25(7):1045-1053. Epub 2019 Jul 1.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences and WT-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF
July 2019

Targeting Huntingtin Expression in Patients with Huntington's Disease.

N Engl J Med 2019 06 6;380(24):2307-2316. Epub 2019 May 6.

From University College London (UCL) Huntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square Institute of Neurology, UCL, and the U.K. Dementia Research Institute at UCL, London (S.J.T., E.J.W.), the Department of Clinical Neuroscience, Addenbrooke's Hospital, University of Cambridge, Cambridge (R.A.B., N.F.B.), Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University NHS Foundation Trust, and the Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester (D.C.), the University of Edinburgh and the U.K. Dementia Research Institute, Edinburgh (J.P.), the Institute of Clinical Sciences, College of Medical and Dental Sciences, University Hospital Birmingham, Birmingham (H.R.), and the Cardiff University Brain Repair Group, Brain Repair and Intracranial Neurotherapeutics Unit, Neuroscience and Mental Health Research Institute and School of Biosciences, Cardiff (A.R.) - all in the United Kingdom; the Centre for Huntington's Disease, Department of Medical Genetics, and the Division of Neurology, Department of Medicine, University of British Columbia, and the Centre for Molecular Medicine and Therapeutics, B.C. Children's Hospital, Vancouver, Canada (B.R.L.); the Department of Neurology, Ulm University, Huntington's Disease Centre, Ulm (G.B.L.), the Department of Neurology, Huntington Center North Rhine-Westphalia, Ruhr University Bochum, St. Josef-Hospital, Bochum (C.S.), and the Department of Neuropsychiatry, Charité-Universitätsmedizin Berlin, Deutsches Zentrum für Neurodegenerative Erkrankungen, Berlin (J.P.) - all in Germany; Ionis Pharmaceuticals, Carlsbad, CA (H.B.K., E.E.S., D.A.N., T.B., E.P., A.V.S., C.F.B., R.M.L.); and F. Hoffmann-La Roche, Basel, Switzerland (C.C., I.G., S.A.S.).

View Article and Find Full Text PDF
June 2019

Parkinson disease and growth factors - is GDNF good enough?

Nat Rev Neurol 2019 Jun;15(6):312-314

Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF
June 2019

Hyperosmotic stress induces cell-dependent aggregation of α-synuclein.

Sci Rep 2019 02 19;9(1):2288. Epub 2019 Feb 19.

John van Geest Centre for Brain Repair, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, United Kingdom.

View Article and Find Full Text PDF
February 2019

Disease-Modification in Huntington's Disease: Moving Away from a Single-Target Approach.

J Huntingtons Dis 2019 ;8(1):9-22

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF
March 2020

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease.

Front Neurol 2018 20;9:946. Epub 2018 Nov 20.

John van Geest Center for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

View Article and Find Full Text PDF
November 2018

iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia.

Exp Neurobiol 2018 Oct 31;27(5):350-364. Epub 2018 Oct 31.

CHA Stem Cell Institute, Department of Biomedical Science, CHA University, Seongnam 13488, Korea.

View Article and Find Full Text PDF
October 2018

Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report.

Stem Cell Reports 2018 11;11(5):1021-1025

The Centre for Stem Cell Systems (ELSI program), The University of Melbourne, Parkville, VIC, Australia.

View Article and Find Full Text PDF
November 2018

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis.

Front Neurol 2018 16;9:870. Epub 2018 Oct 16.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

View Article and Find Full Text PDF
October 2018

Emerging Treatment Approaches for Parkinson's Disease.

Front Neurosci 2018 8;12:693. Epub 2018 Oct 8.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

View Article and Find Full Text PDF
October 2018

Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation.

Cell Rep 2018 08;24(6):1397-1406

Laboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, BMC A11, Lund University, 221 84 Lund, Sweden. Electronic address:

View Article and Find Full Text PDF
August 2018

The clinical heterogeneity of Parkinson's disease and its therapeutic implications.

Eur J Neurosci 2019 02 14;49(3):328-338. Epub 2018 Oct 14.

Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF
February 2019

Regenerative Therapies for Parkinson's Disease: An Update.

BioDrugs 2018 Aug;32(4):357-366

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK.

View Article and Find Full Text PDF
August 2018

New approaches for brain repair-from rescue to reprogramming.

Nature 2018 05 16;557(7705):329-334. Epub 2018 May 16.

Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, Sweden.

View Article and Find Full Text PDF
May 2018

Simple Generation of a High Yield Culture of Induced Neurons from Human Adult Skin Fibroblasts.

J Vis Exp 2018 02 5(132). Epub 2018 Feb 5.

Department of Experimental Medical Science, Wallenberg Neuroscience Center, Division of Neurobiology and Lund Stem Cell Center, Lund University;

View Article and Find Full Text PDF
February 2018

Predicting clinical diagnosis in Huntington's disease: An imaging polymarker.

Ann Neurol 2018 03 13;83(3):532-543. Epub 2018 Mar 13.

The Computational, Cognitive & Clinical Neuroimaging Laboratory (CNL), Division of Brain Sciences, Imperial College London, United Kingdom.

View Article and Find Full Text PDF
March 2018

Using Medical Claims Analyses to Understand Interventions for Parkinson Patients.

J Parkinsons Dis 2018 ;8(1):45-58

Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands.

View Article and Find Full Text PDF
October 2019

Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.

Cell Stem Cell 2017 Nov;21(5):569-573

Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, 606-8507, Kyoto, Japan.

View Article and Find Full Text PDF
November 2017

C-PE2I and F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.

Mov Disord 2018 01 30;33(1):117-127. Epub 2017 Oct 30.

Centre for Neurodegeneration and Neuroinflammation, Division of Brain Sciences, Imperial College London, London, UK.

View Article and Find Full Text PDF
January 2018

Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned?

Front Neurosci 2017 28;11:530. Epub 2017 Sep 28.

Department of Experimental Medical Science, Division of Neurobiology and Lund Stem Cell Center, Wallenberg Neuroscience Center, Lund University, Lund, Sweden.

View Article and Find Full Text PDF
September 2017

Spatial structure normalises working memory performance in Parkinson's disease.

Cortex 2017 11 1;96:73-82. Epub 2017 Sep 1.

Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK; The Brain and Mind Institute, University of Western Ontario, Canada.

View Article and Find Full Text PDF
November 2017

Parkinson disease: Defining PD subtypes - a step toward personalized management?

Nat Rev Neurol 2017 Aug 7;13(8):454-455. Epub 2017 Jul 7.

John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK.

View Article and Find Full Text PDF
August 2017

Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.

Lancet Neurol 2017 08 16;16(8):620-629. Epub 2017 Jun 16.

Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address:

View Article and Find Full Text PDF
August 2017

Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).

Prog Brain Res 2017 7;230:165-190. Epub 2017 Feb 7.

Wallenberg Neuroscience Center, Lund University, Lund, Sweden; Wellcome Trust-MRC Cambridge Stem Cell Institute and John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom. Electronic address:

View Article and Find Full Text PDF
May 2018